410 results
Page 3 of 21
8-K
EX-99.1
0l0yfva8ysungste8
23 Aug 22
Windtree Therapeutics Announces KL4 Surfactant and AEROSURF® Global License Agreement
8:30am
8-K
EX-99.1
azonzueno
23 May 22
The study met its primary endpoint of improved systolic blood pressure (SBP) profile at 6 hours
4:01pm
S-8
EX-99.1
sh9 wtuuzhuvmh
18 May 22
Registration of securities for employees
4:12pm
8-K
EX-99.1
vltk3abubstz
31 Mar 22
Windtree Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Key Business Updates
7:05am
8-K
EX-4.2
qzh9ov7
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
8-K
EX-1.1
nqg8dhtjm7bro
24 Mar 21
Entry into a Material Definitive Agreement
5:20pm
424B5
5u1rpva
24 Mar 21
Prospectus supplement for primary offering
5:14pm